Business
Clinuvel (ASX:CUV) share price falls despite positive update
The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price is tumbling in early morning trade. This comes despite releasing an update to the market. At the time of writing, the biopharmaceutical company’s shares are swapping hands for $27.99, down 2.3%.
What did Clinuvel announce?
The Clinuvel share price is being weighed down by investors despite the company’s positive announcement.
According to this morning’s release, Clinuvel advised that it has now expanded its DNA repair program. The clinical trials will now evaluate afamelanotide in skin cells which have been damaged by ultraviolet (UV) and sun exposure. Patients suffering from rare…
-
General17 hours agoTributes flow after Australian Paralympic bronze medallist Nicholas Hum dies aged 32
-
General13 hours agoNT’s top year 12 achievers celebrated, with some looking to pursue teaching careers
-
General13 hours agoReuven Morrison was killed in the Bondi Beach shooting one year after warning about antisemitism
-
Noosa News14 hours agoAccredited Specialists making a difference – Proctor